How To Effectively Manage Your CTD Dossier Submissions

Learn how to effectively manage your CTD dossier submissions in the pharmaceutical industry. This guide covers the structure, challenges, and best practices for CTD submissions, plus the role of automated tools in enhancing accuracy and compliance for quicker regulatory approvals.

Exploring Innovative Pharmaceutical Industry Solutions

The article "Exploring Innovative Pharmaceutical Industry Solutions" delves into the dynamic advancements transforming the pharmaceutical industry. It highlights the integration of technology such as artificial intelligence in drug discovery, optimization of supply chains, and novel patient engagement strategies. The discussion extends to breakthroughs in gene therapy and monoclonal antibodies, aiming to improve treatment for complex diseases and enhance remission rates with personalized approaches. Moreover, the article covers the pivotal role of market intelligence and digital tools in refining drug development processes and patient care. Emphasizing the need for streamlined operations and compliance with regulations, it also explores innovative packaging solutions that support safety, sustainability, and patient compliance. This comprehensive review serves as a resource for professionals within the pharmaceutical sector and those interested in the latest healthcare innovations.

How to Choose the Best Rilmenidine Generic for Your Needs

Explore the benefits and essentials of choosing the right Rilmenidine generic for hypertension management with our in-depth guide. This article delves into the nuances of Rilmenidine as an effective antihypertensive, highlighting the advantages of generic versions. Learn about dosage, side effects, medication interactions, and tips for selecting reliable suppliers. Equip yourself with the knowledge to make informed health decisions and understand why Rilmenidine generic is a key option in antihypertensive treatments. Perfect for patients and healthcare providers looking to enhance treatment outcomes while managing costs effectively.

15 pharma events for licensing and business development executives in 2024

From dynamic conferences to distinguished symposia, these gatherings bring together intelligent minds, scientists, researchers, policymakers and industry professionals around the world. In this blog, we will explore the 15 pharma events for licensing and business development managers in 2024.

With in-person events back on track, it’s time for pharma marketplaces to reimagine themselves

With the events circuit in full swing after two years of intermittent lockdowns, many pharma manufacturers and buyers can finally meet in person, discuss business opportunities and refresh their knowledge of the ever-changing field. Having recently visited CPHI in Frankfurt myself, I can attest to all these benefits that the industry missed during the pandemic. But what does this “return to normal” mean for B2B marketplaces that have grown in the last few years?

Pipelinepharma adds biosimilars, medical devices and nutraceuticals to its platform

Pipelinepharma, a B2B marketplace with 85 000+ finished dose formulation products, announces adding 3 new categories in addition to generic drugs, vastly expanding its offering.

Tips for submitting an actionable RFQ on the marketplace

At Pipelinepharma, we seek to make all interactions via the B2B marketplace as simple as possible. This includes registration, search, and communication. The same principle of simplicity applies when a pharma buyer decides to submit a request for a quotation (RFQ).

Major drugs going off-patent in 2020-2026 bring opportunities to both manufacturers and buyers

Generics manufacturers have been waiting for something of the same scale as the 2011-2016 Patent Cliff, when the expiration of multiple blockbuster patents coincided, unlocking hundreds of billions in value. Watching drugs going off-patent in 2020-2026, it looks like we are entering a period of increased opportunities and potential.

How can generics manufacturers unlock more business opportunities

The market for generic drugs around the world is only going to grow. At the moment, we see varying market penetration rates across Europe and other developed markets, but due to market trends, in a decade or so, generic penetration across developed markets may well amount to around 80-90%.

Pipelinepharma records quadruple growth over a single year

Marketplaces are a standard staple for many B2B industries. By connecting buyers and sellers in the digital realm, marketplaces significantly reduce dealmaking time and effort. Europe alone lists more than 1700 online marketplaces, with more than 30% aimed at business-to-business transactions.